Results Snapshot
Figures in Rs cr
Standalone Half Yearly Results
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
Half Yearly Analysis Highlights
Net Sales
Growth in half year ended Sep 2024 is 15.38% vs -2.59% in Sep 2023
Standalone Net Profit
Growth in half year ended Sep 2024 is 12.31% vs 12.15% in Sep 2023
Operating Profit (PBDIT) excl Other Income
Growth in half year ended Sep 2024 is 56.00% vs -15.34% in Sep 2023
Interest
Growth in half year ended Sep 2024 is 18.92% vs 825.00% in Sep 2023
Operating Profit Margin (Excl OI)
Growth in half year ended Sep 2024 has improved from Sep 2023
Compare Half Yearly Results Of Jagsonpal Pharma With
Figures in Rs cr
Standalone Half Yearly Results
Change(INR)
Change(%)
Net Sales
136.13
4,933.00
-4,796.87
-97.24%
Other Operating Income
0.00
0.00
0.00
Total Operating income
136.13
4,933.00
-4,796.87
-97.24%
Raw Material Cost
9.59
386.36
-376.77
-97.52%
Purchase of Finished goods
42.07
988.27
-946.20
-95.74%
(Increase) / Decrease In Stocks
-2.99
15.23
-18.22
-119.63%
Employee Cost
31.41
1,047.96
-1,016.55
-97.00%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
29.53
1,170.95
-1,141.42
-97.48%
Total Expenditure (Excl Depreciation)
109.61
3,608.77
-3,499.16
-96.96%
Operating Profit (PBDIT) excl Other Income
26.52
1,324.23
-1,297.71
-98.00%
Other Income
3.10
200.59
-197.49
-98.45%
Operating Profit (PBDIT)
29.62
1,524.82
-1,495.20
-98.06%
Interest
0.44
8.18
-7.74
-94.62%
Exceptional Items
-3.29
61.23
-64.52
-105.37%
Gross Profit (PBDT)
25.89
1,516.64
-1,490.75
-98.29%
Depreciation
3.41
168.82
-165.41
-97.98%
Profit Before Tax
22.48
1,347.82
-1,325.34
-98.33%
Tax
5.69
261.13
-255.44
-97.82%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
16.79
1,086.69
-1,069.90
-98.45%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
61.23
-61.23
-100.00%
Net Profit
16.79
1,147.92
-1,131.13
-98.54%
Equity Capital
13.24
40.06
-26.82
-66.95%
Face Value
5.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
2.54
28.66
-26.12
-91.14%
Diluted Earnings per share
2.49
28.61
-26.12
-91.30%
Operating Profit Margin (Excl OI)
19.48%
26.84%
0.00
-7.36%
Gross Profit Margin
19.02%
30.74%
0.00
-11.72%
PAT Margin
12.33%
22.03%
0.00
-9.70%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 136.13 Cr
in Sep 2024Figures in Rs Cr
Growth in half year ended Sep 2024 is 15.38% vs -2.59% in Sep 2023
Half Yearly - Standalone Net Profit
Standalone Net Profit 16.79 Cr
in Sep 2024Figures in Rs Cr
Growth in half year ended Sep 2024 is 12.31% vs 12.15% in Sep 2023
Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 26.52 Cr
in Sep 2024Figures in Rs Cr
Growth in half year ended Sep 2024 is 56.00% vs -15.34% in Sep 2023
Half Yearly - Interest
Interest 0.44 Cr
in Sep 2024Figures in Rs Cr
Growth in half year ended Sep 2024 is 18.92% vs 825.00% in Sep 2023
Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.48%
in Sep 2024Figures in Rs %
Growth in half year ended Sep 2024 has improved from Sep 2023